These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14985116)

  • 1. Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary hypertension.
    Zhicheng J; Lihe L; Zhiyan H; Xiansheng C; Yubao Z; Yuejin Y; Rutai H
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1033-8. PubMed ID: 14985116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.
    Newman JH; Wheeler L; Lane KB; Loyd E; Gaddipati R; Phillips JA; Loyd JE
    N Engl J Med; 2001 Aug; 345(5):319-24. PubMed ID: 11484688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertension.
    Cahn A; Meiner V; Leitersdorf E; Berkman N
    Isr Med Assoc J; 2004 Mar; 6(3):156-9. PubMed ID: 15055271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
    ; Lane KB; Machado RD; Pauciulo MW; Thomson JR; Phillips JA; Loyd JE; Nichols WC; Trembath RC
    Nat Genet; 2000 Sep; 26(1):81-4. PubMed ID: 10973254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and genetic characteristics of a Chinese family of primary pulmonary hypertension].
    Jing ZC; Lu LH; Zou YB; You SJ; Han ZY; Zhang Q; Yang YJ; Hui RT; Cheng XS
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):199-202. PubMed ID: 15059534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
    Thomson JR; Machado RD; Pauciulo MW; Morgan NV; Humbert M; Elliott GC; Ward K; Yacoub M; Mikhail G; Rogers P; Newman J; Wheeler L; Higenbottam T; Gibbs JS; Egan J; Crozier A; Peacock A; Allcock R; Corris P; Loyd JE; Trembath RC; Nichols WC
    J Med Genet; 2000 Oct; 37(10):741-5. PubMed ID: 11015450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension.
    Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC
    Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.
    Runo JR; Vnencak-Jones CL; Prince M; Loyd JE; Wheeler L; Robbins IM; Lane KB; Newman JH; Johnson J; Nichols WC; Phillips JA
    Am J Respir Crit Care Med; 2003 Mar; 167(6):889-94. PubMed ID: 12446270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a floxed allele of the mouse BMP type II receptor gene.
    Beppu H; Lei H; Bloch KD; Li E
    Genesis; 2005 Mar; 41(3):133-7. PubMed ID: 15736264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.
    Sankelo M; Flanagan JA; Machado R; Harrison R; Rudarakanchana N; Morrell N; Dixon M; Halme M; Puolijoki H; Kere J; Elomaa O; Kupari M; Räisänen-Sokolowski A; Trembath RC; Laitinen T
    Hum Mutat; 2005 Aug; 26(2):119-24. PubMed ID: 15965979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
    Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
    Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.
    Roberts KE; McElroy JJ; Wong WP; Yen E; Widlitz A; Barst RJ; Knowles JA; Morse JH
    Eur Respir J; 2004 Sep; 24(3):371-4. PubMed ID: 15358693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
    Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
    Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene for familial primary pulmonary hypertension identified.
    SoRelle R
    Circulation; 2000 Aug; 102(6):E9010-1. PubMed ID: 10950623
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.
    Morse J; Barst R; Horn E; Cuervo N; Deng Z; Knowles J
    J Rheumatol; 2002 Nov; 29(11):2379-81. PubMed ID: 12415595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of pulmonary arterial hypertension: current and future implications.
    Elliott CG
    Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.